Obesity and the risk of psoriatic arthritis: A population-based study

Annals of the Rheumatic Diseases

Volumn 71, Issue 8, 2012, Pages 1273-1277

  Love, Thorvardur Jon ^a   Zhu, Yanyan ^b   Zhang, Yuqing ^b   Wall Burns, Lindsay ^c,d   Ogdie, Alexis ^e   Gelfand, Joel M ^e   Choi, Hyon K ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; INJURY; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SMOKING;

ARTHRITIS, PSORIATIC; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; RISK ASSESSMENT; UNITED STATES;

EID: 84863828999     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201299     Document Type: Article

References (33)

1. Ogdie A, Gelfand JM. Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. Arch Dermatol 2010;146:785-8.
2. Alenius GM, Stenberg B, Stenlund H, et al. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002;29:2577-82. (Pubitemid 35416965)
3. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005;53:573.
4. Bhosle MJ, Kulkarni A, Feldman SR, et al. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006;4:35.
5. Mallbris L, Ritchlin CT, Ståhle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2006;8:355-63. (Pubitemid 44638828)
6. Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol 2011;147:419-24.
7. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-41. (Pubitemid 44547793)
8. Qureshi AA, Choi HK, Setty AR, et al. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009;145:379-82.
9. Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005;352:1899-912. (Pubitemid 40627816)
10. Hamminga EA, van der Lely AJ, Neumann HA, et al. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006;67:768-73. (Pubitemid 44062144)
11. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007;167:1670-5. (Pubitemid 47280349)
12. Tam LS, Tomlinson B, Chu TT, et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation. Rheumatology (Oxford) 2008;47:718-23. (Pubitemid 351619219)
13. Bhole VM, Choi HK, Burns LC, et al. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) 2012;51:552-6.
14. Soltani-Arabshahi R, Wong B, Feng BJ, et al. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 2010;146:721-6.
15. Blak BT, Thompson M. How does the health improvement network (thin) data on prevalence of chronic diseases compare with national figures? Value Health 2009;12:A253.
16. Seminara NM, Abuabara K, Shin DB, et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol 2011;164:602-9.
17. Singh JA, Holmgren AR, Krug H, et al. Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases. Arthritis Rheum 2007;57:648-55. (Pubitemid 46764056)
18. Rodríguez G, Soriano LC, Choi HK. Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 2010;69:2090-4.
19. Toh S, Rodríguez LA, Hernández-Díaz S. Use of antidepressants and risk of lung cancer. Cancer Causes Control 2007;18:1055-64. (Pubitemid 47498156)
20. Lewis JD, Schinnar R, Bilker WB, et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007;16:393-401. (Pubitemid 46656860)
21. Ruigómez A, Martín-Merino E, Rodríguez LA. Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf 2010;19:579-85.
22. Eder L, Law T, Chandran V, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 2011;63:1091-7.
23. Pattison E, Harrison BJ, Griffiths CE, et al. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 2008;67:672-6. (Pubitemid 351571932)
24. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series. Geneva: World Health Organization, 2000.
25. Gisondi P, Del Giglio M, Di Francesco V, et al. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 2008;88:1242-7.
26. de Menezes Ettinger JE, Azaro E, de Souza CA, et al. Remission of psoriasis after open gastric bypass. Obes Surg 2006;16:94-7.
27. Higa-Sansone G, Szomstein S, Soto F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004;14:1132-4. (Pubitemid 39299743)
28. Hossler EW, Maroon MS, Mowad CM. Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 2011;65:198-200.
29. García Rodríguez LA, Varas-Lorenzo C, Maguire A, et al. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. Circulation 2004;109:3000-6. (Pubitemid 38808323)
30. Martín-Merino E, García-Rodríguez LA, Massó-González EL, et al. Do oral antimuscarinic drugs carry an increased risk of acute urinary retention? J Urol 2009;182:1442-8.
31. Hall GC. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009;18:120-31.
32. Meal A, Leonardi-Bee J, Smith C, et al. Validation of THIN data for non-melanoma skin cancer. Qual Prim Care 2008;16:49-52. (Pubitemid 351454579)
33. Martín-Merino E, Ruigómez A, Johansson S, et al. Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Prim Care Companion J Clin Psychiatry 2010;12:PCC.08m00764.